publication date: Jun. 29, 2018

NCI Director’s Report What NCI did with the money: Sharpless boosts funding for RPGs, centers, SPOREs, NCTN, and NCORP

By Matthew Bin Han Ong

In addition to a $147 million increase to the Research Grant Project pool, NCI has added $60 million to targeted research opportunities and a $20 million increase for centers and SPOREs, and $10 million for the National Clinical Trials Network and the NCI Community Oncology Research Program.

The institute received a $275 million increase over fiscal 2017 levels, bringing NCI’s enacted 2018 budget to $5.66 billion. Of the new funds, NCI leadership invested over half into the RPG pool.

“You can see that there was about almost a $40 million increase in taps, benefits, and salaries,” NCI Director Ned Sharpless said at the June 26 joint meeting of the National Cancer Advisory Board and the Board of Scienific Advisors. “These are things that the NCI has to experience. There’s an increase to our [Small Business Innovation Research program] funding, it’s a fixed grade of our external budget.”

NCI stands to receive an additional $190 million in FY19—out of a $2 billion increase for NIH—if the latest version of the Senate appropriations bill for Labor-HHS is enacted.

Over 20 percent of NCI’s FY18 increase was allocated to specific research opportunities. … Continue reading What NCI did with the money: Sharpless boosts funding for RPGs, centers, SPOREs, NCTN, and NCORP

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.